The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 01, 2021

Filed:

May. 17, 2019
Applicant:

Bausch & Lomb Incorporated, Rochester, NY (US);

Inventors:

Ivan M. Nuñez, Penfield, NY (US);

Katie L. Poetz, Webster, NY (US);

Lynn Coullard, Williamson, NY (US);

Alok Kumar Awasthi, Pittsford, NY (US);

Analuz Mark, Spencerport, NY (US);

Joseph W. Hoff, Fairport, NY (US);

Andrew J. Hoteling, Ontario, NY (US);

Assignee:

Bausch & Lomb Incorporated, Rochester, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G02B 1/04 (2006.01); C08L 83/04 (2006.01); C08K 5/34 (2006.01); C08L 33/10 (2006.01); C08K 5/3412 (2006.01);
U.S. Cl.
CPC ...
G02B 1/043 (2013.01); C08L 83/04 (2013.01); C08K 5/3412 (2013.01); C08L 33/10 (2013.01);
Abstract

A water extractable ophthalmic device is disclosed which is a polymerization product of a monomeric mixture comprising: (a) one or more cyclic lactams; (b) one or more organosilicon-containing block copolymers; (c) one or more bulky siloxane monomers; and (d) a crosslinking agent mixture comprising (i) one or more first crosslinking agents containing at least two ethylenically unsaturated reactive end groups, wherein the at least two ethylenically unsaturated reactive end groups are (meth)acrylate-containing reactive end groups and (ii) one or more second crosslinking agents containing at least two ethylenically unsaturated reactive end groups wherein at least one of the ethylenically unsaturated reactive end groups is a non-(meth)acrylate reactive end group. The water extractable ophthalmic device has an equilibrium water content of at least about 50 wt. %, a contact angle of less than about 50°, and an oxygen permeability of at least about 60 Barrers.


Find Patent Forward Citations

Loading…